On September 12, 2022 Hypertrust Patient Data Care reported that Numerous industry experts will meet there to share insights on the latest technologies in CAR and TCR therapies (Press release, Hypertrust Patient Data Care, SEP 12, 2022, http://www.hypertrust-patient.com/7th-car-tcr-summit-on-the-development-of-safe-effective-and-commercially-viable-car-and-tcr-therapies [SID1234619531]). Developments in the industry are moving incredibly fast, which is exactly why it’s important to stay up-to-date. At Hypertrust Patient Data Care, we are pleased to be a leading company in providing the end-to-end supply chain management solution that is essential for the support of these therapies. We are aware of our responsibility and ready to look optimistically into the future with our existing solution Hypertrust X-Chain. Our heart beats for making Advanced & Personalized Therapies safer and better.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The event will provide an opportunity to gain comprehensive insight from both established thought leaders and innovators who are bringing breakthrough technologies from the lab to the bedside and from the vein to the vein. We look forward to meeting you there!

About 7th CAR-TCR Summit

Over three main conference days and eight tracks, more than 200 CAR and TCR experts will discuss with you and your colleagues novel allogeneic approaches with improved safety aspects, the latest in vivo genetic techniques, and advances in CMC strategies and analytical development to ensure the development of high-quality cell products.